American Heart Journal
Volume 157, Issue 1 , Pages 149-155, January 2009

Three-year clinical outcome after primary stenting of totally occluded native coronary arteries:

A randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study)

  • Braim M. Rahel, MD, PhD

      Affiliations

    • Department of Interventional Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
    • ,
  • Gerrit J. Laarman, MD, PhD

      Affiliations

    • Department of Interventional Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
    • ,
  • Johannes C. Kelder, MD

      Affiliations

    • Department of Research and Statistics, St. Antonius Hospital Nieuwegein, The Netherlands
    • ,
  • Juriën M. ten Berg, MD, PhD

      Affiliations

    • Department of Interventional Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
    • ,
  • Maarten J. Suttorp, MD, PhD, FACC

      Affiliations

    • Department of Interventional Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands
    • Corresponding Author InformationReprint requests: Maarten J. Suttorp, MD, PhD, FESC, FACC, Department of Interventional Cardiology, St. Antonius Hospital Nieuwegein, Koekoekslaan 1, 3435 CM Nieuwegein, The Netherlands.

Received 22 May 2008; accepted 20 August 2008. published online 07 November 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The PRISON II trial is registered with clinicaltrials.gov number NCT 00258596.

PII: S0002-8703(08)00746-1

doi:10.1016/j.ahj.2008.08.025

American Heart Journal
Volume 157, Issue 1 , Pages 149-155, January 2009

Article Tools

* Image Usage & Resolution